Exploring the Power of Semaglutide: A Game-Changer in the Treatment of Obesity

By Dimitri Gitelmaker, MD  Obesity has become a global health epidemic, affecting millions of people worldwide and posing significant health risks. Obesity in the United States affects 42% of adults and 20% of children, and accounts for approximately $147 billion in annual health care costs. Becoming overweight is the leading cause for developing prediabetes, and…

A Comparison of Weight Loss Medications: Topiramate, Bupropion, Naltrexone, Phentermine, and GLP1s

by Dimitri Gitelmaker, MD As a physician board certified in obesity management, I understand the importance of evidence-based information when it comes to prescribing medications for weight loss. In this blog post, I will provide a comprehensive comparison of five popular weight loss medications – topiramate, bupropion, naltrexone, phentermine, and GLP-1 agonists – supported by…

Addressing the Growing Challenge of Pediatric Obesity: A Vital Call to Action

By Dimitri Gitelmaker, MD Pediatric obesity has emerged as a pressing public health concern, affecting millions of children worldwide. The alarming rise in childhood obesity rates is not only linked to immediate health risks but also poses long-term consequences. As a medical expert in obesity medicine, I feel a strong responsibility to shed light on…